Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Clin Immunol ; 40(2): 289-298, 2020 02.
Artigo em Inglês | MEDLINE | ID: mdl-31863244

RESUMO

Chronic granulomatous disease (CGD) is a primary immunodeficiency characterized by life-threatening infections, inflammation, and autoimmunity with an impact on health-related quality of life (HRQoL). Few data are available for children, whereas no study has been conducted in adults. Here, we investigated HRQoL and emotional functioning of 19 children and 28 adults enrolled in Italian registry for CGD. PEDsQL and SDQ were used for children and their caregivers, and adults completed the SF-12 questionnaire. Mean scores were compared with norms and with patients affected by chronic diseases. Comparisons were made for CGD patients who underwent or not hematopoietic stem cell transplantation (HSCT). When compared with norms, CGD children exhibited higher difficulties in social/school areas, peer relationship, and conduct/emotional problems (< 5 years of age), as scored by proxies. Differently, CGD adults reported higher difficulties both in mental and physical area than norms. Only for children, clinical status had a damaging effect on psychosocial and school dimensions, whereas age had a negative impact on social areas. No significant difference was observed between patients treated or not with HSCT. When compared with patients affected by chronic diseases, CGD children and adults both displayed fewer physical disabilities. Differently, in mental scale adults scored lower than those with rheumatology diseases and had similar impairment in comparison with patients with diabetes mellitus and cancer. This study emphasized the impact of CGD on HRQoL since infancy and its decline in adulthood, with emotional difficulties occurring early. HRQoL impairment should be considered in clinical picture of CGD and pro-actively assessed and managed by clinicians.


Assuntos
Doença Granulomatosa Crônica/epidemiologia , Síndromes de Imunodeficiência/epidemiologia , Adolescente , Adulto , Cuidadores , Criança , Pré-Escolar , Resina de Colestiramina , Feminino , Doença Granulomatosa Crônica/psicologia , Humanos , Síndromes de Imunodeficiência/psicologia , Itália/epidemiologia , Masculino , Pessoa de Meia-Idade , Angústia Psicológica , Qualidade de Vida , Sistema de Registros , Índice de Gravidade de Doença , Adulto Jovem
2.
J Pediatr Hematol Oncol ; 37(3): e200-3, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25222056

RESUMO

BACKGROUND: A 17-year-old boy was referred to our center with a history of brain abscess (BA) recurring after 9 years. The patient reported 2 previous treatments for pulmonary arteriovenous malformations, sporadic nosebleeds, and familial history for epistaxis. Clinical investigations revealed arteriovenous malformations in lung, brain, and liver, as well as mucocutaneous telangiectases. A definite diagnosis of hereditary hemorrhagic telangiectasia was made based on clinical criteria and confirmed by genetic analysis. This is the first report of BA recurrence at the end of pediatric age. CONCLUSIONS: The present case and the literature review of all cases of BA thus far reported highlight the need to raise the suspicion of a pulmonary arteriovenous malformations, both isolated and in the context of a possible hereditary hemorrhagic telangiectasia, for any case of BA of unexplained etiology, in children as well as in adults.


Assuntos
Fístula Arteriovenosa/complicações , Abscesso Encefálico/etiologia , Abscesso Encefálico/patologia , Artéria Pulmonar/anormalidades , Veias Pulmonares/anormalidades , Telangiectasia Hemorrágica Hereditária/complicações , Adolescente , Adulto , Fístula Arteriovenosa/terapia , Abscesso Encefálico/cirurgia , Embolização Terapêutica , Humanos , Imageamento por Ressonância Magnética , Masculino , Prognóstico , Recidiva , Telangiectasia Hemorrágica Hereditária/terapia
3.
Ital J Pediatr ; 40: 10, 2014 Jan 25.
Artigo em Inglês | MEDLINE | ID: mdl-24460868

RESUMO

Kabuki syndrome (also called Niikawa-Kuroki syndrome) is a rare genetic disease described for the first time in Japan, characterised by anomalies in multiple organ systems and often associated with autoimmune disorders and impaired immune response. We herein report the clinical history, the therapeutic approach and the outcome of two children with Kabuki syndrome who developed autoimmune haematological disorders (haemolytic anaemia and immune thrombocytopenia). Factors regarding differential diagnosis and interventions in better management of this syndrome and its complications are discussed. This is the first report of Italian children with autoimmune haematological disorders complicating Kabuki syndrome.


Assuntos
Anormalidades Múltiplas/diagnóstico , Anemia Hemolítica Autoimune/diagnóstico , Face/anormalidades , Testes Genéticos/métodos , Doenças Hematológicas/diagnóstico , Imunoglobulinas Intravenosas/uso terapêutico , Prednisolona/uso terapêutico , Púrpura Trombocitopênica Idiopática/diagnóstico , Doenças Vestibulares/diagnóstico , Anormalidades Múltiplas/tratamento farmacológico , Anormalidades Múltiplas/genética , Anemia Hemolítica Autoimune/tratamento farmacológico , Anemia Hemolítica Autoimune/genética , Biópsia por Agulha Fina , Criança , DNA/análise , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/metabolismo , Diagnóstico Diferencial , Quimioterapia Combinada , Feminino , Glucocorticoides/uso terapêutico , Doenças Hematológicas/tratamento farmacológico , Doenças Hematológicas/genética , Humanos , Fatores Imunológicos/uso terapêutico , Masculino , Proteínas de Neoplasias/genética , Proteínas de Neoplasias/metabolismo , Púrpura Trombocitopênica Idiopática/tratamento farmacológico , Púrpura Trombocitopênica Idiopática/genética , Doenças Vestibulares/tratamento farmacológico , Doenças Vestibulares/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA